As treatment with DPP4is exerts no clinically meaningful effects on BNP and NT-proBNP [152], serial monitoring of NT-proBNP in patients with T2DM and ischaemic heart disease may be useful for the identification of patients at highest risk for HF [153]. The gene discussed is NPPB; the disease is hydrops fetalis.